Participants 519 610 6
From February 1991 to December 1994, 376 patients with newly diagnosed CML in chronic phase
Participants 636 687 7
340 patients were Ph/BCR-ABL positive and evaluable
Participants 938 1028 7
a total of 534 patients were evaluable (226 patients with IFN/HU and 308 patients with HU)
Participants 1632 1733 3
Of the 534 patients, 105 (20%) underwent allogeneic stem cell transplantation in first chronic phase.
